IRADIMED uplists to Nasdaq Global Market, trading starts June 14, 2024 under IRMD

IRADIMED CORP

Nasdaq approved transfer from Capital Market to Global Market, effective June 14, 2024.
Ticker remains 'IRMD'; no stockholder action required.
CEO Roger Susi highlights continued growth and enhanced visibility from higher listing standards.
Nasdaq Global Market includes ~1,450 companies with stricter financial and governance requirements.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.